Carroll Financial Associates’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | $137K | Sell |
300
-190
| -39% | -$79.9K | 0.01% | 459 |
|
|
2021
Q3 | $182K | Buy |
490
+32
| +7% | +$12.2K | 0.01% | 412 |
|
|
2021
Q2 | $174K | Buy |
458
+3
| +0.7% | +$1.15K | 0.01% | 443 |
|
|
2021
Q1 | $163K | Buy |
455
+7
| +2% | +$2.25K | 0.01% | 441 |
|
|
2020
Q4 | $143K | Buy |
448
+37
| +9% | +$11.4K | 0.01% | 442 |
|
|
2020
Q3 | $110K | Buy |
411
+31
| +8% | +$8.34K | 0.01% | 460 |
|
|
2020
Q2 | $99K | Buy |
380
+23
| +6% | +$6.14K | 0.01% | 471 |
|
|
2020
Q1 | $81K | Hold |
357
| – | – | 0.01% | 458 |
|
|
2019
Q4 | $107K | Sell |
357
-15
| -4% | -$4.13K | 0.01% | 481 |
|
|
2019
Q3 | $89K | Buy |
372
+15
| +4% | +$4.11K | 0.01% | 531 |
|
|
2019
Q2 | $100K | Buy |
357
+116
| +48% | +$31.7K | 0.01% | 499 |
|
|
2019
Q1 | $69K | Sell |
241
-15
| -6% | -$4.34K | 0.01% | 504 |
|
|
2018
Q4 | $64K | Hold |
256
| – | – | 0.01% | 454 |
|
|
2018
Q3 | $70K | Sell |
256
-100
| -28% | -$26K | 0.01% | 451 |
|
|
2018
Q2 | $84K | Hold |
356
| – | – | 0.01% | 419 |
|
|
2018
Q1 | $78K | Hold |
356
| – | – | 0.01% | 420 |
|
|
2017
Q4 | $80K | Hold |
356
| – | – | 0.01% | 412 |
|
|
2017
Q3 | $68K | Hold |
356
| – | – | 0.01% | 434 |
|
|
2017
Q2 | $66K | Hold |
356
| – | – | 0.01% | 436 |
|
|
2017
Q1 | $58K | Hold |
356
| – | – | 0.01% | 447 |
|
|
2016
Q4 | $51K | Sell |
356
-40
| -10% | -$5.36K | 0.01% | 456 |
|
|
2016
Q3 | $49K | Buy |
396
+254
| +179% | +$32.8K | 0.01% | 461 |
|
|
2016
Q2 | $18K | Buy |
142
+17
| +14% | +$2.33K | ﹤0.01% | 645 |
|
|
2016
Q1 | $17K | Sell |
125
-100
| -44% | -$13.4K | ﹤0.01% | 643 |
|
|
2015
Q4 | $31K | Sell |
225
-14
| -6% | -$1.93K | 0.01% | 485 |
|
|
2015
Q3 | $34K | Buy |
239
+7
| +3% | +$1.05K | 0.01% | 467 |
|
|
2015
Q2 | $38K | Buy |
232
+92
| +66% | +$14.7K | 0.01% | 425 |
|
|
2015
Q1 | $22K | Hold |
140
| – | – | 0.01% | 400 |
|
|
2014
Q4 | $19K | Sell |
140
-179
| -56% | -$22.1K | 0.01% | 395 |
|
|
2014
Q3 | $40K | Hold |
319
| – | – | 0.01% | 344 |
|
|
2014
Q2 | $34K | Buy |
319
+185
| +138% | +$19.1K | 0.01% | 378 |
|
|
2014
Q1 | $13K | Buy |
134
+94
| +235% | +$8.5K | ﹤0.01% | 483 |
|
|
2013
Q4 | $3K | Sell |
40
-60
| -60% | -$5.33K | ﹤0.01% | 669 |
|
|
2013
Q3 | $8K | Hold |
100
| – | – | ﹤0.01% | 557 |
|
|
2013
Q2 | $8K | Buy |
+100
| New | +$7.48K | ﹤0.01% | 439 |
|
Other funds holding ELV
Carroll Financial Associates's ELV Position: Q4 2021 in Review
Carroll Financial Associates reduced its Elevance Health (ELV) stake by 39% in Q4 2021, selling an estimated $79.9K and leaving 300 shares worth $137K. The position accounts for 0.01% of the portfolio, ranked #459.
Carroll Financial Associates first reported a position in ELV in Q2 2013 and has held it in 35 quarters since. The position peaked at $182K in Q3 2021. 1,372 funds tracked by Wall St. Rank hold ELV as of Q4 2021.
- Carroll Financial Associates held 300 shares of Elevance Health worth $137K as of Q4 2021.
- Carroll Financial Associates sold 190 Elevance Health shares in Q4 2021, an estimated $79.9K.
- Elevance Health made up 0.01% of Carroll Financial Associates's portfolio in Q4 2021, its #459 holding.
- Carroll Financial Associates first reported a position in Elevance Health in Q2 2013 and has held it in 35 quarters since.
- Carroll Financial Associates's Elevance Health position peaked at $182K in Q3 2021.
- 1,372 funds tracked by Wall St. Rank held Elevance Health as of Q4 2021.
Based on Carroll Financial Associates's 13F filing for Q4 2021, filed 6 Jan 2022.